Informed Consent in Healthcare and Research: Ethical Principles, Practical Challenges, and Emerging Directions - A Narrative Review

Review History

Published: 2026-09-19

DOI: 10.9734/bpi/mreca/v4/7934

Page: 37-66


Pheagane Motsime William Nkoana *

University of Limpopo, Polokwane, South Africa.

Mapula Precious Rapao

University of Limpopo, Polokwane, South Africa.

*Author to whom correspondence should be addressed.


Abstract

Informed consent is both an ethical authorisation and a communicative process through which patients and research participants are enabled to make decisions that accord with their values. Its normative foundations are well established, yet persistent gaps between formal requirements and lived practice challenge the assumption that a signed form reliably indicates understanding or voluntariness. This critical narrative review integrates ethical theory, clinical communication, research ethics, empirical studies of comprehension, intervention evidence, and emerging digital and data-intensive practices. Literature from 1947 to 5 July 2026 was identified through multidisciplinary scholarly sources, supplemented by authoritative ethics and regulatory documents and citation searching. The evidence indicates that valid consent depends on decision-specific capacity, material and comprehensible disclosure, meaningful opportunity for questions and deliberation, freedom from controlling influence, and an affirmative authorisation. Across both clinical care and research, comprehension is frequently incomplete, particularly for probabilistic risk, randomisation, placebo use, alternatives, and the distinction between research and individualised care. The strongest intervention evidence favours interactive communication, test-feedback or teach-back approaches, professional language support, and well-designed digital or multimedia tools, whereas readability improvement or document shortening alone produces inconsistent benefits. Research consent additionally confronts therapeutic misconception, payment and structural pressures, emergency enrolment, paediatric assent, broad consent for secondary use, and the governance of longitudinal data. Electronic and dynamic consent can improve access, traceability and participant control, but may also transfer burdens to participants and reproduce digital inequities. Artificial intelligence raises a newer question: when algorithmic involvement is sufficiently material to require notification or explicit consent. The review argues that consent quality should be judged less by document completion and more by supported decision-making, proportionate communication, validated assessment where stakes or vulnerability are high, and governance that protects autonomy without treating individuals as isolated decision-makers. Future research should prioritise outcome-valid consent measures, equity-sensitive intervention trials, and context-specific standards for digital and artificial-intelligence-mediated decision support.

Keywords: Autonomy, decision-making capacity, electronic consent, research ethics, shared decision-making, therapeutic misconception, voluntariness


How to Cite

Nkoana, P. M. W., & Rapao, M. P. (2026). Informed Consent in Healthcare and Research: Ethical Principles, Practical Challenges, and Emerging Directions - A Narrative Review. Medical Research: Emerging Concepts and Applications Vol. 4, 37–66. https://doi.org/10.9734/bpi/mreca/v4/7934